Caspases are essential proteases in programmed cell death and inflammation. Studies in murine and human cells have led to the characterization of 14 members of this enzyme family. Here we report the identification of caspase-15, a novel caspase that is expressed in various mammalian species including pig, dog, and cattle. The caspase-15 protein contains a catalytic domain with all amino acid residues critical for caspase activity and a prodomain that is predicted to fold into a pyrin domain structure, which is a unique feature among mammalian caspases. Recombinant porcine caspase-15 underwent autocatalytic processing into its subunits and cleaved both tetrapeptide caspase substrates and the apoptosis regulator protein Bid in vitro. Overexpression of caspase-15 in mammalian cells induced proenzyme maturation, cleavage of Bid, activation of caspase-3, and eventually cell death. Both the proteolytic and the pro-apoptotic activity of caspase-15 were abolished by mutation of the active site cysteine. Since a homolog of caspase-15 is absent in the human and the mouse genome, our results reveal an unexpected variability in the molecular apoptotic machinery of mammals.
Caspases are essential proteases in programmed cell death and inflammation. Studies in murine and human cells have led to the characterization of 14 members of this enzyme family. Here we report the identification of caspase-15, a novel caspase that is expressed in various mammalian species including pig, dog, and cattle. The caspase-15 protein contains a catalytic domain with all amino acid residues critical for caspase activity and a prodomain that is predicted to fold into a pyrin domain structure, which is a unique feature among mammalian caspases. Recombinant porcine caspase-15 underwent autocatalytic processing into its subunits and cleaved both tetrapeptide caspase substrates and the apoptosis regulator protein Bid in vitro. Overexpression of caspase-15 in mammalian cells induced proenzyme maturation, cleavage of Bid, activation of caspase-3, and eventually cell death. Both the proteolytic and the pro-apoptotic activity of caspase-15 were abolished by mutation of the active site cysteine. Since a homolog of caspase-15 is absent in the human and the mouse genome, our results reveal an unexpected variability in the molecular apoptotic machinery of mammals.
Proteases of the caspase family play central roles in apoptosis, also known as programmed cell death, and inflammation (1-3). 14 mammalian caspases have been described so far. Caspase-1 through caspase-10 and caspase-14 are expressed in human cells. Caspase-11 and -12 have been identified in mouse. The human ortholog of caspase-12 is non-functional in the majority of the population because of deleterious mutations in its open reading frame (4, 5) . Caspase-13, which has been considered initially to be a human protease, represents the bovine homolog of human caspase-4 (6). Caspase-2, -8, -9, -10, and -12 function as initiators of a pro-apoptotic proteolytic cascade, which leads to the activation of the so-called apoptosis executioner proteases, caspase-3, -6, and -7. The latter cleaves various cellular proteins that are required for survival. The primary function of caspase-1, -4, and -5 as well as their non-human homologs caspase-11 and -13 is in the processing of proforms of interleukin-1␤ and interleukin-18, two pro-inflammatory cytokines (7) . Several proapoptotic caspases such as caspase-3 and -8 have additional roles apart from those in apoptosis (8, 9) , and caspase-14 is activated in epidermal keratinocyte differentiation but not in apoptosis (10, 11) .
Caspases are expressed as proenzymes consisting of a prodomain and a catalytic domain. The catalytic domain consists of two subunits, p20 and p10, which, upon proteolytic processing of the proenzyme, assemble into a heterotetrameric complex, (p20/p10) 2 . The enzymatic activity of caspases shows a unique cleavage site specificity for 4-amino acid motifs ending with an aspartate residue, which ensures proper maturation of caspase zymogens and specific cleavage of substrates. In contrast to the catalytic domain, which is structurally conserved, the prodomain differs significantly among caspases. Whereas pro-apoptotic executioner caspases and caspase-14 have a short prodomain of less than 30 amino acids, all other caspases have prodomains of more than 80 amino acids length (12) . Long prodomains generally assume structures belonging to the death domain superfamily, which comprises adapters in apoptotic and inflammatory signaling (13, 14) . A caspase recruitment domain (CARD) 2 is present in caspase-1, -2, -4, -5, -9, -11, -12, and -13, and two death effector domains form the prodomains of caspase-8 and -10. Recently, two zebrafish caspases (caspy and caspy2) with a pyrin domain (PYD) prodomain were described (15) .
Here we have identified and characterized a novel mammalian caspase that has a PYD-like prodomain and induces apoptosis upon overexpression. A caspase-15 version with a cysteine-to-serine mutation at the active site (C258S) was generated using a site-directed mutagenesis kit (Stratagene). For expression in bacteria, the region encoding the catalytic domain of porcine caspase-15 (amino acids 136 -368) was subcloned into the bacterial expression vector pET-23a(ϩ) (Novagen) whereby a C-terminal His 6 -tag was attached.
MATERIALS AND METHODS

Cloning of Porcine
Characterization of Caspase-15 Activity in Vitro-The catalytic domain of caspase-15 with the wild-type sequence or a C258S mutation was expressed in the Escherichia coli strain BL21 Star TM (DE3)pLysS (Invitrogen), purified over a nickel-charged affinity resin (Invitrogen), and analyzed by SDS-PAGE. Proteins were detected either by silver staining or immunoblotting using an antiHis-tag antibody (Invitrogen) as first step reagent. For determination of the N-terminal sequences of the recombinant caspase-15 fragments, the proteins were resolved by SDS-PAGE and transferred to a polyvinylidene difluoride membrane. After staining with Coomassie Brilliant Blue, the bands were excised and subjected to Edman degradation at the Protein Service Laboratory of the Swiss Federal Institute of Technology, Zurich, Switzerland. Enzymatic activity was analyzed by incubation of recombinant caspase-15 with 100 M caspase substrate IETD-pNA (Apotech) in a reaction buffer containing 10 mM EDTA, 50 mM NaCl, 10 mM dithiothreitol, 0.1% CHAPS and 5% glycerol, 50 mM Hepes (pH 7.2) with and without 8 M z-Val-Ala-Asp-fluoromethyl ketone (z-VAD-fmk) (Alexis) and measuring absorbance at 405 nm at various time points. For the determination of proteolytic activity, 5 pmol of active caspase-15, as determined by active-site titration using non-methylated z-VAD-fmk (16), or 1 unit of recombinant active caspase-8 (Alexis), were added to 3 g of recombinant Bid (R&D Systems) in a total volume of 40 l of the same reaction buffer as above. Bid is a Bcl-2 family protein, which is converted into a pro-apoptotic fragment by caspase-8-mediated processing at a cleavage site (LQTD-G) that is conserved in multiple species (including human, mouse, pig, dog, and cattle). After incubation at 37°C for 3 h the samples were analyzed by SDS-PAGE and silver staining of the gel as well as by Western blot analysis for Bid.
Overexpression of Caspase-15 in 293T Cells and Characterization of Proapoptotic Activity-293T cells were transfected with pcDNA3.1 with and without caspase-15 using Lipofectamine2000 (Invitrogen). 24 h after transfection cell cultures were assessed for morphological criteria of apoptosis, and cell * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. were prepared from heparinized blood samples of pig, cattle, dog, sheep, goat, and horse by Ficoll gradient centrifugation. Total RNA was prepared using TRIzol reagent according to the manufacturer's instructions (Invitrogen). First-strand cDNA synthesis was performed with 1 g of RNA, 60 units of murine leukemia virus reverse transcriptase (Roche Applied Science), and 2.5 M oligo(dT) primers in a 20-l reaction volume. Partial caspase-15 cDNAs were amplified using the primers 5Ј-CGGAAGGCCTTC-CTCATGTG-3Ј and 5Ј-AATAATCACTGAATGTAGGCAGC-3Ј, and the PCR products were sequenced.
Real-time PCR-RNA was extracted from pig tissues using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. First-strand cDNA synthesis was performed with 1 g of total RNA, 60 units of murine leukemia virus reverse transcriptase (Roche Applied Science), and 2.5 M oligo(dT) primers in a 20-l reaction volume. 1 l of cDNA was subjected to quantitative real-time PCR on a thermal cycler (LightCycler, Roche Applied Science) according to a standard protocol. Pig caspase-15 was amplified with the primers 5Ј-GCCTGCAGAGGAGAGAGAAG-3Ј and 5Ј-TGATCATCACAGAG-CCGGTA-3Ј. In parallel, the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase was amplified with the primers 5Ј-AAGCTTGCT-GGTGAAAAGGA-3Ј and 5Ј-GGGACTCCAGATGTTTCCAA-3Ј. The identity of PCR products was confirmed by sequence analysis.
RESULTS AND DISCUSSION
Caspase-15 Is a Novel Mammalian Caspase-We searched non-rodent and non-primate mammalian ESTs and genome sequences in the GenBank
TM for homologs of murine and human caspases. In addition to orthologs of known caspases (data not shown), we identified a caspase-like cDNA clone that was derived from a porcine embryo cDNA library. The C terminus of the protein encoded by this cDNA showed significant sequence similarity to the catalytic domain of caspases, with the highest similarity found for caspase-14 (36% sequence identity at the amino acid level) (Fig. 1A) . This region was preceded by 126 amino acids that do not have an equivalent in caspase-14 (see below). In the genome of the dog, a gene with 84% nucleotide sequence identity to this cDNA and a separate caspase-14 gene were found, indicating that the novel gene was not merely an ortholog of caspase-14 (Fig. 1A) . Since the new caspase homolog had all the structural characteristics of a caspase including a conserved active site (SHG box and QACRG motif), we tentatively named it caspase-15. Alignment to other members of the caspase family revealed that caspase-14 and -15 constitute a subfamily of mammalian caspases that is most similar to mammalian caspases with a CARD prodomain and to the fish caspases caspy and caspy2 (Fig. 1B) .
BLAST comparison of the N-terminal sequence of caspase-15 against the GenBank TM revealed similarity to members of the death domain superfamily. When compared with representatives of all four families of death domain-like structures, the caspase-15 prodomain clustered with the PYDs of human pyrin, human ASC, and zebrafish caspy (Fig. 1C) . Residues recently identified to be critical for the PYD structure (17, 18) and for homotypic PYD-PYD interactions (19) were present in the caspase-15 prodomain (Fig. 1D) . This suggested that caspase-15 is the first and, according to our extensive homology screening of translated genome databases, the only mammalian caspase containing a PYD. Although the prodomains of caspase-15 and caspy showed considerable similarity, complete sequence alignment indicated that caspy and caspy2 were related more closely to the caspase-1 subfamily than to caspase-15 (Fig. 1B) . This suggested that caspase-15 has evolved independently from these fish caspases.
Caspase-15 was expressed both in pig embryos, from which it was originally cloned, and, at variable levels, in all adult organs investigated (Fig. 1E) . By reverse transcription-PCR with primers annealing in conserved regions of porcine and canine caspase-15, orthologous mRNAs were detected in PBMCs of cattle, sheep, goat, and horse but not in murine or human cells. BLAST analyses of finished genome sequences confirmed that a caspase-15 ortholog does not exist in mouse or man nor in non-mammalian animals (e.g. fish, frog, and chicken) whose genome sequences are available at present.
Caspase-15 Is Proteolytically Active-To investigate the enzymatic activity of caspase-15, we produced a recombinant protein corresponding to the catalytic domain of caspase-15 in E. coli. Like other members of this protease family (16), caspase-15 readily underwent autoproteolytic processing into two subunits ( Fig.  2A) . N-terminal sequencing of the small fragment yielded the sequence DVSEK, indicating that this subunit was generated by cleavage after the motif MDSD in the intersubunit linker region. The N terminus of the large fragment of caspase-15 was identical to the translation start of the recombinant open reading frame (MDCYD). Caspase-15 cleaved the tetrapeptide caspase substrate IETD-pNA (Fig. 2B ) and, with lower efficiency, also YVAD-pNA and WEHD-pNA (data not shown). Both auto-activation and peptidolytic activity were blocked by mutation of the active site cysteine to a serine residue and WEHDase activity was suppressed gray (charged residues) backgrounds (19) . The bottom lines indicate the location of ␣ helices (h) in the structure of ASC and NALP1 (17, 18) . fsh, zebrafish; NALP1, NACHT-, LRR-and PYD-containing protein 1. E, the relative levels of caspase-15 mRNA in pig organs were determined by real-time PCR using hypoxanthine-guanine phosphoribosyltransferase mRNA levels as a reference standard. The data were then normalized to the expression in PBMC (peripheral blood mononuclear cells). Error bars indicate standard deviations. by the caspase inhibitor z-VAD-fmk (Fig. 2, A and B) . Since caspase-15 had a similar cleavage site preference as caspase-8 (20), we investigated its capacity to cleave the caspase-8 substrate Bid (21) . Indeed, caspase-15 processed Bid into three fragments in vitro (Fig. 2C) . Two Bid fragments (tBid-N and t-Bid-C1) were identical in size to those produced by caspase-8, including the Bid fragment (Bid-C1) that was previously shown to initiate the mitochondrial apoptosis pathway (21) . The third Bid fragment (tBid-C2), which was observed only after processing with caspase-15 but not with caspase-8, was most likely generated by processing of Bid at the second caspase cleavage site described previously (21, 22) (Fig. 2C) .
Overexpression of Caspase-15 Induces Apoptosis-To evaluate whether caspase-15 is able to initiate pro-apoptotic signaling in vivo, we transiently transfected 293T cells with various caspase-15 constructs (Fig. 3A) . Expression of the caspase-15 proenzyme and its processing were detected by Western blot analysis specific for the C-terminal V5 tag of recominant caspase-15. Wildtype caspase-15, but not caspase-15 mutated at its active site, underwent proteolytic maturation as demonstrated by detection of a p10 subunit (Fig. 3A) . In addition to procaspase-15 and the p10 fragment, a 30-kDa protein containing the C-terminal tag became detectable after transfection of wild-type and mutated caspase-15 (Fig. 3A) . This protein may represent the product of initiation of translation at an alternative start codon or the product of cleavage of procaspase-15 by another protease.
The expression of caspase-15 with a wild-type active site induced processing of both Bid and procaspase-3 (Fig. 3A) . Immunofluorescence double labeling and Hoechst staining revealed that cells expressing caspase-15 contained activated caspase-3 and condensed nuclear chromatin (Fig. 3B) . The vast majority of cells transfected with caspase-15 showed signs of apoptosis such as rounding, membrane blebbing, and nuclear condensation within 24 h after transfection, whereas cells transfected with caspase-15, mutated at the active site, showed no increase in apoptosis as compared with control transfections (Fig.  3A) . Overexpression of caspase-15 in the porcine cell line, PK-15, also induced apoptosis (data not shown). Together, these results demonstrated that caspase-15 is a pro-apoptotic protease.
The identification of a novel mammalian caspase is surprising as the molecular apoptotic machinery is generally considered to be highly conserved. Our demonstration that caspase-15 cleaves Bid strongly suggests that caspase-15-positive mammals have a unique mechanism to activate the apoptosis pathway controled by this protein. Future investigations will address whether caspase-15 also processes other substrates, some of which may be specific for these animals. Furthermore, a possible caspase-1-like role of caspase-15 in the processing of pro-inflammatory cytokines cannot be excluded at present. Activation of endogenous caspase-15 proenzyme is likely to involve PYD-mediated recruitment to a multiprotein complex analogous in function to the apoptosome, the death-inducing signaling complex or the inflammasome (12) . Since caspase-15 is the only mammalian caspase with a PYD prodomain, the upstream signaling events leading to its activation may be unique, which suggests a non-redundant role of caspase-15. Consequently, animal species with and without caspase-15 appear to regulate at least some apoptosis-related processes differently. This may have implications for the choice of animal models for certain aspects of human molecular physiology.
